Innate immunity alone is not sufficient for chronic rejection but predisposes healed allografts to T cell-mediated pathology

Transplant Immunology

Volumn 26, Issue 2-3, 2012, Pages 113-118

  Zecher, Daniel ^a   Li, Qi ^a   Williams, Amanda L ^a   Walters, John T ^a   Baddoura, Fady K ^b   Chalasani, Geetha ^a,c   Rothstein, David M ^a,c   Shlomchik, Warren D ^d   Demetris, Anthony J ^a,c   Lakkis, Fadi G ^a,c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

B 1 lymphocytes; Chronic rejection; Innate immunity; NK cells

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; IMMUNOLOGICAL ADJUVANT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CARDIAC GRAFT REJECTION; CELLULAR IMMUNITY; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; DISEASE PREDISPOSITION; GRAFT RECIPIENT; HEALING; HISTOPATHOLOGY; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; LYMPHOID TISSUE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; SPLENECTOMY; T LYMPHOCYTE ACTIVATION;

ANIMALS; B-LYMPHOCYTE SUBSETS; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNITY, INNATE; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 84862791571     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2011.12.006     Document Type: Article

References (28)

1. Hall B.M. Cells mediating allograft rejection. Transplantation 1991, 51:1141-1151.
2. Miller J.F.A.P. Effect of neonatal thymectomy on the immunological responsiveness of the mouse. Proc R Soc Lond B Biol Sci 1962, 156:415-428.
3. Hall B.M., Dorsch S., Roser B. The cellular basis of allograft rejection in vivo. I. The cellular requirements for first-set rejection of heart grafts. J Exp Med 1978, 148:878-889.
4. Bingaman A.W., Ha J., Waitze S.-Y., Durham M.M., Cho H.R., Tucker-Burden C., et al. Vigorous allograft rejection in the absence of danger. J Immunol 2000, 164:3065-3071.
5. Russell P.S., Chase C.M., Sykes M., Ito H., Shaffer J., Colvin R.B. Tolerance, mixed chimerism, and chronic transplant arteriopathy. J Immunol 2001, 167:5731-5740.
6. Larsen C.P., Elwood E.T., Alexander D.Z., Ritchie S.C., Hendrix R., Tucker-Burden C., et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996, 381:434-438.
7. Shimizu K., Schonbeck U., Mach F., Libby P., Mitchell R.N. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis. J Immunol 2000, 165:3506-3518.
8. Salama A., Remuzzi G., Harmon W., Sayegh M. Challenges to achieving clinical transplantation tolerance. J Clin Invest 2001, 108:943-948.
9. Libby P., Pober J.S. Chronic rejection. Immunity 2001, 14:387-397.
10. Graham J.A., Wilkinson R.A., Hirohashi T., Chase C.M., Colvin R.B., Madsen J.C., et al. Viral infection induces de novo lesions of coronary allograft vasculopathy through a natural killer cell-dependent pathway. Am J Transplant 2009, 9:2479-2484.
11. Uehara S., Chase C.M., Kitchens W.H., Rose H.S., Colvin R.B., Russell P.S., et al. NK cells can trigger allograft vasculopathy: the role of hybrid resistance in solid organ allografts. J Immunol 2005, 175:3424-3430.
12. Maier S., Tertilt C., Chambron N., Gerauer K., Huser N., Heidecke C.D., et al. Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28-/- mice. Nat Med 2001, 7:557-562.
13. McNerney M.E., Lee K.M., Zhou P., Molinero L., Mashayekhi M., Guzior D., et al. Role of natural killer cell subsets in cardiac allograft rejection. Am J Transplant 2006, 6:505-513.
14. Kroemer A., Xiao X., Degauque N., Edtinger K., Wei H., Demirci G., et al. The innate NK cells, allograft rejection, and a key role for IL-15. J Immunol 2008, 180:7818-7826.
15. Corry R.J., Winn H.J., Russel P.S. Primarily vascularized allografts of hearts in mice: the role of H-2D, H-2K, and non H-2 antigens. Transplantation 1973, 16:343-350.
16. Chalasani G., Dai Z., Konieczny B.T., Baddoura F.K., Lakkis F.G. Recall and propagation of allospecific memory T cells independent of secondary lymphoid organs. Proc Natl Acad Sci USA 2002, 99:6175-6180.
17. Zecher D., Li Q., Oberbarnscheidt M.H., Demetris A.J., Shlomchik W.D., Rothstein D.M., et al. NK cells delay allograft rejection in lymphopenic hosts by downregulating the homeostatic proliferation of CD8+ T cells. J Immunol 2010, 184:6649-6657.
18. Gavin A.L., Hoebe K., Duong B., Ota T., Martin C., Beutler B., et al. Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science 2006, 314:1936-1938.
19. Zecher D., Van Rooijen N., Rothstein D.M., Shlomchik W.D., Lakkis F.G. An innate response to allogeneic nonself mediated by monocytes. J Immunol 2009, 183:7810-7816.
20. Zhang M., Alicot E.M., Chiu I., Li J., Verna N., Vorup-Jensen T., et al. Identification of the target self-antigens in reperfusion injury. J Exp Med 2006, 203:141-152.
21. Chalasani G., Li Q., Konieczny B.T., Smith-Diggs L., Wrobel B., Dai Z., et al. The allograft defines the type of rejection (acute versus chronic) in the face of an established effector immune response. J Immunol 2004, 172:7813-7820.
22. Lakkis F. Reply to "confounding variables complicate conclusions in aly model". Nat Med 2001, 7:1165-1166.
23. Lanier L. NK cell recognition. Annu Rev Immunol 2005, 23:225-274.
24. Hankey K.G., Drachenberg C.B., Papadimitriou J.C., Klassen D.K., Philosophe B., Bartlett S.T., et al. MIC expression in renal and pancreatic allografts. Transplantation 2002, 73:304-306.
25. Kitchens W.H., Uehara S., Chase C.M., Colvin R.B., Russell P.S., Madsen J.C. The changing role of natural killer cells in solid organ rejection and tolerance. Transplantation 2006, 81:811-817.
26. Zhang M., Austen W.J., Chiu I., Alicot E., Hung R., Ma M., et al. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc Natl Acad Sci (USA) 2004, 101:3886-3891.
27. Hirohashi T., Uehara S., Chase C.M., DellaPelle P., Madsen J.C., Russell P.S., et al. Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice. Am J Transplant 2010, 10:510-517.
28. Kitchens W.H., Chase C.M., Uehara S., Cornell L.D., Colvin R.B., Russell P.S., et al. Macrophage depletion suppresses cardiac allograft vasculopathy in mice. Am J Transplant 2007, 7:2675-2682.